UNSPSC 51283801: Dalfopristin

This classification denotes an antibiotic with the molecular formula C34H50N4O9S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier R9M4FJE48E, chemically known as virginiamycin m1, 26-((2-(diethylamino)ethyl)sulfonyl)-26,27-dihydro-, (26r,27s)- but generally known as dalfopristin, which bears US NIH Compound Identifier 6323289. European Medicines Agency schedules Dalfopristin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06892MIG.

UNSPSC 51283801 Dalfopristin is a Commodity code that in practice covers pharmaceutical procurement by state and local health agencies, though recent opportunities tagged under this code show substantial mismatch with the nominal product scope. State and local governments use codes in this family to buy prescription medications and medical supplies through consolidated purchasing vehicles, often via cooperative contracts and piggyback arrangements that leverage statewide or multi-state consortia. The Illinois Department of Public Health and Seminole County, Florida appear as recent buyers, using procurement frameworks that include competitive bidding (IFB) and existing cooperative contracts to source both acute-care pharmaceuticals and community health supplies. Issuing bodies in this space tend to be state health departments and county public-health or community-health agencies rather than schools, cities, or transit authorities.

Recent activity shows geographic concentration in Florida and Illinois. The Illinois Department of Public Health awarded a $2,999,999.11 piggyback pharmaceutical warehouse contract to Chartwell Rx LLC through the MMCAP Infuse consortium on August 28, 2026, for Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets under IFB 26-482DPH-PREPD-B-53392 with a 12-month initial term and two renewal options. Seminole County, Florida released an IFB (60459723LAS) on June 30, 2026, for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, response deadline July 26, 2023. Neither solicitation directly involves Dalfopristin; the code's recent posting activity reflects broader pharmaceutical and medical-supply acquisition rather than this specific antibiotic product line.